Reshape Lifesciences Inc Stock Nasdaq
Equities
US7611234052
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 9.99M | Sales 2025 * | 11.99M | Capitalization | 3.8M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.38 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.32 x |
P/E ratio 2024 * |
-0.36
x | P/E ratio 2025 * |
-0.45
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
Latest transcript on Reshape Lifesciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 20-01-31 |
Director of Finance/CFO | 63 | 21-06-14 | |
Dov Gal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 15-12-31 |
Dan Gladney
CHM | Chairman | 70 | 15-10-31 |
Director/Board Member | 70 | 21-06-14 |
1st Jan change | Capi. | |
---|---|---|
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
-0.27% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |